Fred Kemp

Data, Digital Health, Innovation, Leadership

📍 Greater Oxford Area, United Kingdom🔄 Updated October 2026💼 6 investments📅 10 years investing🗓 Last invested May 2019𝕏 @upgrade_to_unlock
VC🌍 United Kingdom
6
Total investments
6
Early stage
0
Mid stage
0
Late stage
10y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
May 2019
Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.
Board Observer
Jun 2017
Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure. Learn more: https://www.ultromics.com/. Follow Ultromics on social media for the latest news, X: https://x.com/ultromics, LinkedIn: https://www.linkedin.com/company/ultromics/.
Board Observer
May 2016
See protein, DNA and RNA molecules that make life work, in nanoparticles, viruses, bacteria, cells and tissue. We believe that understanding science at a molecular level will fundamentally allow you to unlock new discoveries, so we created our flagship product, The Nanoimager. We built the worlds first desktop compatible compact super-resolution microscope, but we did it our way. Our teams have a restless enthusiasm to bring technologies like super-resolution to a new community of researchers and we continue working until barriers of accessibility and affordability are addressed. Our mission is to ensure research and collaboration tools are available to those willing to ask why or how things are the way they are and answer questions never asked before. We can’t wait to see and hear about what new questions you will ask!
early stageBiotechnology
Board Observer
Feb 2016
Delivering explainable AI faster and more accurately. Zegami are end-to-end imaging AI specialists combining unique tools and machine learning services. We have built up years of expertise and experience in AI, working alongside researchers, data scientists and clinicians on a wide range of AI and ML projects that use imaging data.
Board Observer
Feb 2016
Delivering explainable AI faster and more accurately. Zegami are end-to-end imaging AI specialists combining unique tools and machine learning services. We have built up years of expertise and experience in AI, working alongside researchers, data scientists and clinicians on a wide range of AI and ML projects that use imaging data.
Board Observer
Jan 2016
Navenio has developed infrastructure-free, highly scalable, accurate and robust indoor location solutions - built on award-winning and world leading research from the University of Oxford - that utilise existing smartphone devices to localise people within a broad range of contexts and markets. The Navenio solution provides a dramatic improvement on other indoor localisation technologies, having the ability to locate people without the need for implementing, managing or surveying any new building hardware such as beacons or wi-fi. As a result, Navenio can deliver highly scalable and frictionless indoor location solutions for everyone, everywhere.
Experience · 8 entries
All (8)
Investments (6)
Board (6)
2019
Board Observer
May 2019
Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.
2017
Board Observer
Jun 2017
Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure. Learn more: https://www.ultromics.com/. Follow Ultromics on social media for the latest news, X: https://x.com/ultromics, LinkedIn: https://www.linkedin.com/company/ultromics/.
2016
Board Observer
May 2016
See protein, DNA and RNA molecules that make life work, in nanoparticles, viruses, bacteria, cells and tissue. We believe that understanding science at a molecular level will fundamentally allow you to unlock new discoveries, so we created our flagship product, The Nanoimager. We built the worlds first desktop compatible compact super-resolution microscope, but we did it our way. Our teams have a restless enthusiasm to bring technologies like super-resolution to a new community of researchers and we continue working until barriers of accessibility and affordability are addressed. Our mission is to ensure research and collaboration tools are available to those willing to ask why or how things are the way they are and answer questions never asked before. We can’t wait to see and hear about what new questions you will ask!
early stageBiotechnology
Board Observer
Feb 2016
Delivering explainable AI faster and more accurately. Zegami are end-to-end imaging AI specialists combining unique tools and machine learning services. We have built up years of expertise and experience in AI, working alongside researchers, data scientists and clinicians on a wide range of AI and ML projects that use imaging data.
Board Observer
Feb 2016
Delivering explainable AI faster and more accurately. Zegami are end-to-end imaging AI specialists combining unique tools and machine learning services. We have built up years of expertise and experience in AI, working alongside researchers, data scientists and clinicians on a wide range of AI and ML projects that use imaging data.
Show all 8 entries ↓
Investment activity
2016–2019 · 6 investments
201642017120191
Recent (last 2 years)Earlier